Evidence map›Paper›PMID 25302681›Full record

ArticleSeminars in thrombosis and hemostasis2014

Thrombosis: a major contributor to global disease burden.

Gary E Raskob, Pantep Angchaisuksiri, Alicia N Blanco, Harry Büller, Alexander Gallus, Beverley J Hunt, Elaine M Hylek, The Lord Kakkar, Stavros V Konstantinides, Micah McCumber and 4 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Seminars in thrombosis and hemostasis, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed, 3 pooled it
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 3 syntheses or guidelines pooled it, 140 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Review
  14. Venous thromboembolisms and stroke risk in patients with atrial fibrillation: a nationwide cohort study.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025
    Article
  15. Review
  16. Comparison of half-dose alteplase and LMWH in intermediate-high risk pulmonary embolism: a single-center observational study.The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology · 2025
    Article
  17. Article
  18. Article
  19. Article
  20. Review

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 11 institutions in 9 countries.

Gary E RaskobCollege of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
Pantep AngchaisuksiriFaculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Alicia N BlancoDivision of Hemostasia, Academia Nacional de Medicina, Buenos Aires, Argentina.
Harry BüllerDepartment of Vascular Medicine, Academic Medical Center, Amsterdam, The Netherlands.
Alexander GallusDepartment of Hematology, SA Pathology, Flinders Medical Center, Adelaide, South Australia, Australia.
Beverley J HuntThrombosis and Thrombophilia Centre, Guy's and St Thomas NHS Foundation Trust, London, United Kingdom.
Elaine M HylekSection of General Internal Medicine, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts.
The Lord KakkarThrombosis Research Institute, London, United Kingdom.
Stavros V KonstantinidesCenter for Thrombosis and Hemostasis, University Medical Center, Johannes Gutenberg University, Mainz, Germany.
Micah McCumberCollege of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
Yukio OzakiDepartment of Laboratory Medicine, University of Yamanashi, Yamanashi, Japan.
Aaron WendelboeCollege of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
Jeffrey I WeitzThrombosis and Atherosclerosis Research Institute, and McMaster University, Hamilton, Ontario, Canada.
ISTH Steering Committee for World Thrombosis Day
University of Oklahoma Health Sciences Center · USAcademia Nacional de Medicina · ARAmsterdam UMC Location University of Amsterdam · NLBoston University · USGuy's and St Thomas' NHS Foundation Trust · GBJohannes Gutenberg University Mainz · DEMahidol University · THSouth Australia Pathology · AUThrombosis and Atherosclerosis Research Institute · CAThrombosis Research Institute · GBUniversity of Yamanashi · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thrombosis is a common pathology underlying ischemic heart disease, ischemic stroke, and venous thromboembolism (VTE). The Global Burden of Disease Study 2010 (GBD 2010) documented that ischemic heart disease and stroke collectively caused one in four deaths worldwide. GBD 2010 did not report data for VTE as a cause of death and disability. We performed a systematic review of the literature on the global disease burden due to VTE in low-, middle-, and high-income countries. Studies from Western Europe, North America, Australia, and Southern Latin America (Argentina) yielded consistent results with annual incidences ranging from 0.75 to 2.69 per 1,000 individuals in the population. The incidence increased to between 2 and 7 per 1,000 among those 70 years of age or more. Although the incidence is lower in individuals of Chinese and Korean ethnicity, their disease burden is not low because of population aging. VTE associated with hospitalization was the leading cause of disability-adjusted-life-years (DALYs) lost in low- and middle-income countries, and second in high-income countries, responsible for more DALYs lost than nosocomial pneumonia, catheter-related blood stream infections, and adverse drug events. VTE causes a major burden of disease across low-, middle-, and high-income countries. More detailed data on the global burden of VTE should be obtained to inform policy and resource allocation in health systems, and to evaluate if improved utilization of preventive measures will reduce the burden.

Identifiers

PMID25302681
OpenAlexW2086721960

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.